Method for the treatment of the symptoms of drug and alcohol addiction
A therapeutic agent for the treatment of the symptoms of addiction and the method for preparing the therapeutic agent is disclosed. The therapeutic agent is a stable pharmaceutical preparation containing, but not limited to, digestive/pancreatic enzymes. The therapeutic agent may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic agent may be made orally, through injection, by adherence of a medicated patch or other method. Further, a method of using of a biomarker, the presence of chymotrypsin in the gastrointestinal tract to determine the presence of symptoms of addiction, and the likelihood of relapsing into addiction is disclosed.
1. A method for treating an alcohol or drug addicted individual exhibiting one or more symptoms of alcohol or drug addiction, wherein the one or more symptoms is selected from the group consisting of a lack of protein digestion, a lack or nutrient absorption and a combination thereof the method comprising:
(a) obtaining a fecal sample from the individual;
(b) measuring a level of chymotrypsin present in the fecal sample;
(c) administering a therapeutically effective amount of digestive enzymes to the individual if the measured fecal level of chymotrypsin is less than 8.4 U/gram; wherein the digestive enzymes are selected from the group consisting of pancreatin, amylases, lipases, proteases and a combination thereof.
2. The method of claim 1 , wherein the proteases comprise chymotrypsin, trypsin, papain or a combination thereof.
3. The method of claim 1 , wherein the digestive enzymes are prepared using a technology selected from the group consisting of enteric coating, lipid encapsulation, direct compression, dry granulation, wet granulation and a combination thereof.
4. The method of claim 1 , wherein the digestive enzymes are administered orally via a dosage formulation selected from the group consisting of pills, tablets, capsules, microcapsules, mini-capsules, time released capsules, mini-tabs, sprinkles, and a combination thereof.
5. The method of claim 1 , wherein the amount of amylases ranges from 10,000 to 60,000 USP units/dose.
6. The method of claim 1 , wherein the amount of proteases ranges from 10,000 to 70,000 USP units/dose.
7. The method of claim 1 , wherein the amount of lipases ranges from 4,000 to 30,000 USP units/dose.
8. The method of claim 2 , wherein the amount of pancreatin ranges from 2,000 to 6,000 USP units/dose.
9. The method of claim 2 , wherein the amount of papain ranges from 3,000 to 10,000 USP units/dose.
10. The method of claim 2 , wherein the amount of trypsin ranges from 60 to 100 mg.
11. The method of claim 1 , wherein the one or more symptoms of the drug or alcohol addiction is ameliorated.
12. The method of claim 1 , wherein the total amount of the digestive enzymes ranges from about 4,000 to about 176,000 USP units/dose.